RenovoRx annual free cash flow
2024
2025
RenovoRx Free Cash Flow (FCF) History (RNXT)
RenovoRx reported −$11.0M in free cash flow for fiscal 2025, a decrease of $1.8M from the previous fiscal year, with a free cash flow margin of −977.29%.
View full RenovoRx company overviewRenovoRx free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$11.0M | −$1.8M | — | −977.29% |
| 2024 | 2024-12-31 | −$9.1M | — | — | −21248.84% |
RenovoRx quarterly free cash flow
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.9M | −$636,000 | — | −323.21% |
| Q1 2026 | 2026-03-31 | −$3.7M | −$326,000 | — | −658.79% |
| Q4 2025 | 2025-12-31 | −$3.0M | — | — | −1268.91% |
| Q3 2025 | 2025-09-30 | −$2.3M | — | — | −853.38% |
| Q2 2025 | 2025-06-30 | −$2.3M | — | — | −545.50% |
| Q1 2025 | 2025-03-31 | −$3.4M | — | — | −1717.26% |
RenovoRx free cash flow growth trends
RenovoRx's latest reported quarter, Q2 2026, generated −$2.9M in free cash flow, a decrease of $636,000 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review RenovoRx filings at SEC.gov ↗